All times are US Eastern Daylight Time (GMT-4). All events will start 10 mins before the scheduled times to allow the speakers and the participants to login.

Wednesday, March 29, 2023

Time Short Courses # Instructors
9:00am – 12:00pm Introduction to Bayesian Methods for Clinical Trial Design and Sample Size Determination C1A Joseph G. Ibrahim
Real World Evidence Framework in Clinical Development  C2 Laura Fernandez, Freda Cooner
Reproducible Data Analysis Pipelines in R C3 Will Landau
Randomized Phase II Trials C4 Sin-Ho Jung
12:00pm – 1:00pm Break
1:00pm-4:00pm Introduction to Bayesian Methods for Clinical Trial Design and Sample Size Determination C1B Joseph G. Ibrahim
Regulatory/Statistical Consideration of Biosimilar Product Development C3 Tom Gwise, Shein-Chung Chow
Multi-Regional Clinical Trial C4 Bruce Binkowitz
Artificial Intelligence in Health Research C6 Mark Chang

Thursday, March 30, 2023

Time Session/Event # Organizers
9:00am – 10:30am Opening Remarks and Keynote I
John Concato
10:30am – 10:45am Break
10:45am – 12:00pm (75mins) Estimand in Oncology  SA1 Jingjing Schneider, Qing Xu
Patient Centric Trials SA2 Colleen Russell, Shuyen Ho
Software and Data Standardization and Integrity  SA3 Fang Chen, Shibing Deng
Patient Centric Trials SA4 Fang Chen, Freda Cooner
Integrated Analysis of RCTs and Population-based Studies S1E Shu Yang
12:00pm – 1:00pm Poster Session ???Ying Yang, Marlina Nasution
1:00pm – 2:15pm (75mins) Benefit Risk Assessment: Case Studies SB1 Anastasia Ivanova, Shibing Deng
General Considerations for RWE/RWD Studies SB2 Qing Xu , Freda Cooner , Xiaofei Wang
Current Issues in Data Monitoring Committees: Moderated Panel Session SB3 Jingjing Schneider, Shibing Deng
Statistical Considerations for Rare Disease Clinical Trials S2D Yeh-Fong Chen, Freda Cooner, Jean Pan
Clinical Experience for Cancer Immunotherapy Trial Design S2E Anastasia Ivanova, Freda Cooner
2:15pm – 2:30pm Break
2:30pm – 4:30pm (120mins) Information Borrowing in Rare Disease and Non-Oncology Clinical Trials SC1 Rakhi Kilaru, Qiming Liao, Freda Cooner
Data Monitoring Committee SC2 Marlina Nasution, Shuyen Ho, Robert Barrier
Centralized Statistical Monitoring Tools in Trial Conduct SC3 Rakhi Kilaru
Master Protocols S3D Miaomiao Ge, Freda Cooner, Anastasia Ivanova
Data Quality, Integrity and Risk Management Considerations in Clinical Trials S3E Rakhi Kilaru

Friday, April 23, 2021

Time Session/Event # Speakers/organizers
8:00am – 9:00am Keynote II Xiaofei Wang
9:00am – 9:15am Break
9:15am – 10:30am (75mins) Leadership in Statistical Consulting S4A Alexander Schacht
Artificial Intelligence in Health Care Research S4B Xiaofei Wang
Use of Companion Diagnostics (CoDx) in Clinical Trials S4C Sudhakar Rao
Statistical Methodology for Cancer Immunology Trial Design S4D Jianrong Wu
Biomarker-driven Trials with Adaptive Threshold Detection S4E Miaomiao Ge, Freda Cooner
10:30am – 10:45am Break
10:45am – 12:45pm (120mins) Combination Therapy in Oncology Clinical Development S5A Freda Cooner, Qi Jiang, Anastasia Ivanova
Digital / Mobile Health in Clinical Trials S5B Kevin Anstrom
Analytical and Methodological Challenges in the Study of Complex Liver Diseases S5C Ayako Suzuki
Better Evidence Synthesis via Innovative Methods S5D Haitao Chu
Interactive Visualization Tools S5E Richard Payne, Freda Cooner
11:45am – 2:30pm Job Fair